SCD and esophageal squamous cell carcinoma: Increased levels of SCD1 are observed in a panel of esophageal squamous cell carcinoma (ESCC) cell lines and the targeting of SCD1 by MF-438 is pursued by Luo and colleagues for increasing IR potency (Luo et al., 2022).